54.00GBp+15.63%Mkt Cap: 31.74M GBpP/E: —Last update: 2026-05-13
Novacyt S.A., together with its subsidiaries, develops, manufactures, and commercializes a range of molecular assays and instrumentation to deliver workflows and services for human health, animal health, and environmenta…
Industry Peers
Medical Devicesloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)-0.07
PEG—
P/B0.79
P/S1.69
EV/EBITDA-0.72
EV/Revenue0.31
EPS (TTM)-0.33
EPS (Forward)-6.96
Cash Flow & Leverage
FCF Yield68.86%
FCF Margin112.36%
Operating CF-9.15M GBp
CapEx (TTM)1.86M GBp
Net Debt/EBITDA1.52
Net Debt-12.77M GBp
Technical
SMA 5035.00 (+54.3%)
SMA 20037.32 (+44.7%)
Beta0.97
S&P 52W Chg24.23%
Avg Vol (30d)260.57K
Avg Vol (10d)1.59M
Technical Indicators
RSI (14)81.4
MACD2.6718
MACD Signal0.3842
MACD Hist.+2.2876
BB Upper46.67 GBp
BB Middle33.58 GBp
BB Lower20.49 GBp
BB Width77.98%
ATR (14)5.293 GBp
Vol Ratio (20d)4.10x
52W Range
26.6071% of range65.20
52W High65.20 GBp
52W Low26.60 GBp
Profitability
Gross Margin163.39%
EBITDA Margin-43.19%
Profit Margin-212.73%
Oper. Margin-64.91%
ROE-87.21%
ROA-59.12%
Revenue Growth-1.80%
Earnings Growth—
Balance Sheet
Debt/Equity0.25
Current Ratio5.03
Quick Ratio4.34
Book Value/Sh0.5780 GBp
Cash/Share0.3360 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBp
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Ownership
Shares Out.72.44M
Float70.41M
Insiders0.06%
Institutions0.00%
Analyst Consensus
Rating—
Target (Mean)6600.00 GBp
Target Range6600.00 GBp – 6600.00 GBp
# Analysts1
Company
Market Cap31.74M GBp
Enterprise Value6.02M GBp
Revenue (TTM)19.45M GBp
Gross Profit32.07M GBp
Net Income (TTM)-41.76M GBp
Revenue/Share0.2750 GBp
Fiscal Year EndDec 2024
MR QuarterJun 2025
Employees234
Last Price54.00 GBp
CountryGB
SectorHealthcare
IndustryMedical Devices
ISINFR0010397232